Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637689 · ClinicalTrials.gov registry record
Improving Outcomes Assessment in Chronic GVHD
A clinical trial of Chronic Graft Versus Host Disease, sponsored by Fred Hutchinson Cancer Center.
- Active
- Registry status
- 601
- Enrollment target
- 9
- Study locations
NCT00637689: Active study of Chronic Graft Versus Host Disease, sponsored by Fred Hutchinson Cancer Center.
NCT00637689 is a study of Chronic Graft Versus Host Disease that is active but no longer recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 601 participants, above the 96-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (526% higher). The trial reports 9 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00637689, a study of Chronic Graft Versus Host Disease, is active but no longer recruiting, sponsored by Fred Hutchinson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 601 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to see if recent guidelines proposed by the National Institutes of Health for the diagnosis, staging, and response assessment of people with chronic GVHD can improve our understanding of this complication. We will accomplish our goals by studying a large number of people with chronic GVHD over several years using information collected from health care providers, patients, laboratory studies and diagnostic tests. Several transplant centers in the United States are collaborating on this project.
Conditions Studied
Study Locations (9)
California
- Stanford University - Stanford
Florida
- H. Lee Moffitt Cancer Center - Tampa
Massachusetts
- Dana-Farber Cancer Institute - Boston
Minnesota
- University of Minnesota - Minneapolis
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering - New York
Tennessee
- Vanderbilt University - Nashville
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2007-09 |
| Est. Completion | 2027-02 |
What the registry record for NCT00637689 still lists
NCT00637689 is an observational study that tracks outcomes without assigning an intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 30 other Chronic Graft Versus Host Disease trials with a reported enrollment target (526% higher).
The record links to 1 condition, with Chronic Graft Versus Host Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00637689 lists 9 locations in 9 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00637689 about?
NCT00637689 is a clinical study titled "Improving Outcomes Assessment in Chronic GVHD". The purpose of this study is to see if recent guidelines proposed by the National Institutes of Health for the diagnosis, staging, and response assessment of people with chronic GVHD can improve our understanding of this complication. We will accomplish our goals by studying a large number of people...
What is the current status of trial NCT00637689?
This trial is currently active not recruiting. The enrollment target is 601 participants. The study started on 2007-09. Estimated completion is 2027-02.
What conditions does trial NCT00637689 study?
This clinical trial studies the following conditions: Chronic Graft Versus Host Disease.
Who is sponsoring clinical trial NCT00637689?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00637689 being conducted?
This trial has 9 study locations across California, Florida, Massachusetts, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Graft Versus Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00637689's enrollment target sits among peer trials
601 2nd of 30 the highest of 30 other Chronic Graft Versus Host Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Graft Versus Host Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
A Long-term Extension Study of PCI-32765 (Ibrutinib)
RECRUITING · Phase 3
-
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
RECRUITING
-
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RECRUITING · Phase 2
-
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RECRUITING · Phase 2
-
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia